Common Stock, Shares, Outstanding of Avalo Therapeutics, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Avalo Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Avalo Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 17,827,635, a 84% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Avalo Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 17,827,635 +8,145,261 +84% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 10,837,356 +9,803,226 +948% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 10,827,620 +9,793,490 +947% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 10,471,934 +9,670,188 +1206% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 9,682,374 -182,700,045 -95% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 1,034,130 -13,002,810 -93% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 1,034,130 -12,166,405 -92% 31 Mar 2024 10-Q/A 11 Jul 2024 2024 Q1
Q4 2023 801,746 +762,452 +1940% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 192,382,419 +182,968,315 +1944% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 14,036,940 +4,631,216 +49% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 13,200,535 -99,593,668 -88% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 39,294 -9,360,223 -100% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 9,414,104 -102,903,725 -92% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 9,405,724 -86,603,227 -90% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 112,794,203 +23,689,387 +27% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 9,399,517 -65,604,610 -87% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 112,317,829 +37,417,782 +50% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 96,008,951 +21,108,904 +28% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 89,104,816 +29,544,564 +50% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 75,004,127 +30,619,905 +69% 31 Dec 2020 10-K 02 Mar 2022 2021 FY
Q3 2020 74,900,047 +30,793,253 +70% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 74,900,047 +32,001,796 +75% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 59,560,252 +16,806,593 +39% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 44,384,222 +3,580,033 +8.8% 31 Dec 2019 10-K 08 Mar 2021 2020 FY
Q3 2019 44,106,794 +3,427,160 +8.4% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 42,898,251 +9,107,565 +27% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 42,753,659 +11,343,324 +36% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 40,804,189 +9,537,200 +31% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q3 2018 40,679,634 +14,624,777 +56% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 33,790,686 +19,675,827 +139% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 31,410,335 +20,509,170 +188% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 31,266,989 +21,832,848 +231% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 26,054,857 +16,979,714 +187% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 14,114,859 +5,464,716 +63% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 10,901,165 +2,251,022 +26% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 9,434,141 +783,998 +9.1% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 9,075,143 +8,425,422 +1297% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 8,650,143 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 8,650,143 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 8,650,143 +8,000,422 +1231% 31 Dec 2015 10-K 14 Mar 2017 2016 FY
Q3 2015 649,721 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q4 2014 649,721 31 Dec 2014 10-K 23 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.